Remove Access Remove Clinical Trials Remove Collective Remove eCommerce
article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

Products will be distributed through Valens’ Australian Distribution Partner, Cannvalate PTY Ltd (“Cannvalate”), and will be the largest quantity of products provided to Cannvalate for distribution to date (collectively, the “ Transaction “). Epsilon also operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Access 97